Monoclonal antibody BIS-1

N/A

Report date: 2026/03/19 17:23:44

Base Information

Drug NameMonoclonal antibody BIS-1

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionImmunostimulantsEpithelial cell adhesion molecule inhibitorsT cell surface glycoprotein CD3 inhibitors

TargetsT cell surface glycoprotein CD3Epithelial cell adhesion molecule

Therapy Area/IndicationsAscitesPleural Effusion, MalignantCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Hospital Groningen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Hospital Groningen

Active IndicationsN/A

Inactive IndicationsAscitesPleural Effusion, MalignantCarcinoma, Renal Cell

Other Information

ATC CodeN/A